IMPELLA CP 0048-0003

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2016-02-10 for IMPELLA CP 0048-0003 manufactured by Abiomed Europe, Gmbh (germany).

Event Text Entries

[37922621] Following the reported issue removing the device from the patient, and the subsequent required surgery to remove the detached portions of the impella cp cannual, the physician reported that he did not clearly understand that attempting to remove an impella through the percolse sutures is not recommended by abiomed or abbott, the manufacturer of the perclose device. The abiomed representative has provided retraining of the physician and the cath lab manager and staff. In addition, the abiomed representative has set up future in-service dates to help educate any new staff members and to provide ongoing education to the team. The impella cp was not returned for evaluation, so no device analysis could be performed. The manufacturer will continue to investigate all reasonable obtainable sources of information and will provide results and conclusions in a supplemental medwatch report if additional information is received.
Patient Sequence No: 1, Text Type: N, H10


[37922622] The complainant reported that a (b)(6) male cardiomyopathy patient had an impella cp placed using a perclose on (b)(6) 2016. The patient was reported to have clean arteries, and was diagnosed as takotsubo. The patient was supported with the pump for 66. 13 hours. The patient was reported to have been doing well. All drips were stopped and the weaning process was begun on (b)(6) 2016. The impella cp patient support was reported as successful. On (b)(6) 2016 the pump was explanted from the patient. The physician explained that during explant the nurse helping in the procedure paused while pulling the device out, as she had observed blood coming from the outlet area and then stopped pulling. At that moment the physician was cinching down the sutures. After much force the device broke free and he was able to complete the pre-close process, and again there was bleeding observed from the site. The patient was reported to have remained in stable condition during the removal of the impella cp. Following removal of the impella cp the physician noticed a "spring like" wire coming from the femoral artery. It was also noticed that the pigtail was not present. The physician explained that it appeared that the cannula had come apart leaving the pigtail, the inlet and part of the cannula still in the common femoral artery. The patient was then taken to surgery for removal of the remaining portions of the catheter. All remaining portions or the cannula were successfully removed from the patient. The patient was reported to have subsequently expired on (b)(6) 2016. The physician stated that the patient outcome was not as result of any issue with the device, but was due to the underlying heart issues that brought the patient to the hospital.
Patient Sequence No: 1, Text Type: D, B5


[40744437] Following the submittal of the initial mdr by abiomed for this event, the customer submitted user mdr report 199273664-2016-0001. This user mdr provided additional information not submitted on the initial mdr, and reported different information than was originally reported on abiomed's initial mdr. This supplemental mdr is correcting information previously submitted, adding additional information reported by the customer in their user mdr and additional information obtained during meetings with the complainant, and an abiomed's clinical review of the event. Corrected information: death: (b)(6) 2016. Relevant tests/laboratory data, including dates: (b)(6) 2016 @ 05:17 hgb 8. 7 hct 26. 2, (b)(6) 2016 @ 14:45 hgb 8. 0 hct 25. 9, (b)(6) 2016 @ 15:10 lactic acid 5. 6, (b)(6) 2016 @ 11:14 lactic acid 1. 8, (b)(6) 2016 @ 11:14 ck 631 trop 41. 72 all high, but down from high values of (b)(6) 2016 @ 05:17 ck 998 ck-mb 134. 6. Other relevant history, including preexisting medical condition: nstemi, history of hypothyroidism, no known allergies,. This visit-septic shock , acute coronary syndrome, cad with stenosis of lad, atrial fibrillation, cardiogenic shock, takotsubo cardiomyopathy, acute coronary syndrome. Concomitant products: left internal jugular 3 lumen central venous catheter (b)(6) 2016. Clinical review of the event this was an implant of an impella cp on (b)(6) 2016 at 20:33 for takotsubo cardiomyopathy. In addition to takotsubo, the (b)(6) year old patient presented with septic shock, acute coronary syndrome, coronary artery disease (cad) with stenosis of the left anterior descending (lad) artery, atrial fibrillation, cardiogenic shock and a non-st elevated myocardial infarction (nstemi). The patient had a previous medical history of hyperthyroidism. The impella cp was implanted along with a perclose suture mediated closure (smc) system (abbott laboratories), utilizing the preclose technique for post-explant hemostasis. After implant on (b)(6) 2016, the patient was reported as doing well. All drips were stopped and the weaning process was begun on (b)(6) 2016. The following day, the pump was explanted. During removal of the impella, the physician reported the nurse pulling the impella out hesitated when she saw blood coming from the arteriotomy site. At the same time, the physician was cinching down the sutures on the perclose smc device. It was reported that removal of the impella pump required great force before the physician could complete the perclose procedure. Following removal of the impella pump, bleeding continued from the arteriotomy site. In consultation with an abiomed clinical representative, the physician reported seeing a "spring-like" wire coming from the patient's femoral artery. He also stated there was no pigtail present on the explanted impella catheter. It was concluded that the cannula had come apart during the removal of the impella, leaving the pigtail, inflow cage and distal part of the cannula in the patient's common femoral artery. The patient was taken to vascular surgery to have the pump components removed. After surgery the patient was transferred to the cardiac icu where he suffered a cardiac (pea) arrest and expired at 15:20 on (b)(6) 2016. Following the case, an abiomed clinical representative met with the physician and the catheter lab manager to discuss the case. It was reported that the physician did not understand that attempting to remove an impella through the perclose sutures is not recommended by abiomed or abbott. The abiomed representative has provided retraining of the physician and the cath lab manager and staff. The abiomed representative also set up future in-service dates to providing ongoing education to the team and any new staff members. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1220648-2016-00002
MDR Report Key5427992
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2016-02-10
Date of Report2016-01-11
Date of Event2016-01-11
Date Facility Aware2016-01-11
Date Mfgr Received2016-03-03
Device Manufacturer Date2015-09-14
Date Added to Maude2016-02-10
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag0
Reprocessed and Reused Flag3
Reporter OccupationRISK MANAGER
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. WILLIAM BOLT
Manufacturer Street22 CHERRY HILL DRIVE
Manufacturer CityDANVERS MA 01923
Manufacturer CountryUS
Manufacturer Postal01923
Manufacturer Phone9786461451
Manufacturer G1ABIOMED EUROPE, GMBH (GERMANY)
Manufacturer StreetNEUEHOFER WEG 3
Manufacturer CityAACHEN, GERMANY 13059, GM
Manufacturer CountryGM
Manufacturer Postal Code13059, GM
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameIMPELLA CP
Generic NameIMPELLA CP
Product CodePBL
Date Received2016-02-10
Model NumberIMPELLA CP
Catalog Number0048-0003
Lot Number1203967
Device Expiration Date2017-06-01
OperatorPHYSICIAN
Device AvailabilityN
Device Age4 MO
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerABIOMED EUROPE, GMBH (GERMANY)
Manufacturer AddressNEUEHOFER WEG 3 AACHEN, GERMANY 13059, GM GM 13059, GM


Patients

Patient NumberTreatmentOutcomeDate
101. Death; 2. Required No Informationntervention 2016-02-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.